Results 41 to 50 of about 21,319 (117)

Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing

open access: yesCell Reports, 2019
Summary: CRISPR-Cas9 systems provide powerful tools for genome editing. However, optimal employment of this technology will require control of Cas9 activity so that the timing, tissue specificity, and accuracy of editing may be precisely modulated.
Bianca Garcia   +13 more
doaj   +1 more source

DNA targeting by compact Cas9d and its resurrected ancestor

open access: yesNature Communications
Type II CRISPR endonucleases are widely used programmable genome editing tools. Recently, CRISPR-Cas systems with highly compact nucleases have been discovered, including Cas9d (a type II-D nuclease).
Rodrigo Fregoso Ocampo   +13 more
doaj   +1 more source

Dramatic Improvement of CRISPR/Cas9 Editing in Candida albicans by Increased Single Guide RNA Expression

open access: yesmSphere, 2017
The clustered regularly interspaced short palindromic repeat system with CRISPR-associated protein 9 nuclease (CRISPR/Cas9) has emerged as a versatile tool for genome editing in Candida albicans.
Henry Ng, Neta Dean
doaj   +1 more source

AcrIIA19 binds to the WED domain and inhibits various Cas9 orthologs at multiple stages

open access: yesCommunications Biology
Anti-CRISPR (Acr) proteins are natural inhibitors of clustered regularly interspaced short palindromic repeat (CRISPR)–CRISPR-associated protein (Cas) systems, providing valuable tools for regulating genome editing. Here, we present the crystal structure
Gi Eob Kim   +4 more
doaj   +1 more source

Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing

open access: yesNature Communications
Type VI CRISPR enzymes have been developed as programmable RNA-guided Cas proteins for eukaryotic RNA editing. Notably, Cas13 has been utilized for site-targeted single base edits, demethylation, RNA cleavage or knockdown and alternative splicing ...
David N. Fiflis   +10 more
doaj   +1 more source

CRISPR/Cas as a tool to overcome drug resistance in cancer: From challenge to opportunity

open access: yesMolecular and Cellular Probes
Drug resistance remains a significant challenge in cancer therapy, often resulting in treatment failure, tumor progression, and metastasis. The underlying resistance mechanisms—including genetic mutations, epigenetic alterations, and modifications in ...
Bashdar Mahmud Hussen   +7 more
doaj   +1 more source

TracrRNA reprogramming enables direct PAM-independent detection of RNA with diverse DNA-targeting Cas12 nucleases

open access: yesNature Communications
Many CRISPR-Cas immune systems generate guide (g)RNAs using trans-activating CRISPR RNAs (tracrRNAs). Recent work revealed that Cas9 tracrRNAs could be reprogrammed to convert any RNA-of-interest into a gRNA, linking the RNA’s presence to Cas9-mediated ...
Chunlei Jiao   +8 more
doaj   +1 more source

CRISPR/Cas9 technology in tumor research and drug development application progress and future prospects

open access: yesFrontiers in Pharmacology
The CRISPR/Cas9 system is an acquired immune defense mechanism that has evolved in bacteria and archaea to protect against viral and plasmid attacks. It consists of regularly spaced clusters of short palindromic repeats (CRISPR) and CRISPR-associated ...
Han Han   +5 more
doaj   +1 more source

Testing multiplexed anti-ASFV CRISPR-Cas9 in reducing African swine fever virus

open access: yesMicrobiology Spectrum
African swine fever (ASF) is a highly fatal viral disease that poses a significant threat to domestic pigs and wild boars globally. In our study, we aimed to explore the potential of a multiplexed CRISPR-Cas system in suppressing ASFV replication and ...
Zezhong Zheng   +14 more
doaj   +1 more source

Unveiling the invisible genomic dynamics

open access: yesExperimental and Molecular Medicine
CRISPR-based imaging technologies have emerged as powerful tools for visualizing specific genomic loci, providing groundbreaking insights into chromatin structure and dynamics. Here, in this Review, we discuss the development and recent advances in these
Jiwoong Kwon, Yeji Park, Taekjip Ha
doaj   +1 more source

Home - About - Disclaimer - Privacy